NIH Grants Return Strong ROI Despite Delays – What It Means for Biotech Funding
BioTrinity, April 14-15, 2026, London
LSX World Congress Europe, March 25-26, 2026, Lisbon
RESI Europe, March 23, 2026, Lisbon
BioEurope Spring, March 23-25, 2026, Lisbon
RNA Leaders Europe, March 17-19, 2026, Vienna
BIO Investment & Growth Summit, March 2-3, 2026, Miami
Investival USA, March 10-11, 2026, Miami
Sachs Associates European Neuroscience Innovation Forum, March 3, 2026, Zurich
Sachs Associates European Life Sciences CEO Forum, March 4-5, 2026, Zurich
The Floodgates are Open: Why Waiting for SBIR Reauthorization is Now a Fiduciary Risk
Show Me the Money – Why Investors Undervalue SBIR Grants
Recent Posts
BioFuture, October 27-28, 2026, NYCAugust 2, 2026 - 6:59 am
RESI Boston, September 22-23, 2026, Boston, USAJuly 30, 2026 - 8:42 am
LSX USA Congress, September 23-24, 2026, Boston, USAJuly 30, 2026 - 8:37 am
The 2026 Mid-Year Non-Dilutive Funding Landscape ReportJuly 20, 2026 - 9:44 am
SBIR Is Back — Here’s What Changed and What You Need to Do NowJune 16, 2026 - 8:03 am